Camlin Fine Sciences Limited — Others, 08-08-2025: Change in Management

Camlin Fine Sciences' board has approved its Q1 financial results. Standalone revenue from operations was ₹191.44 Cr, with a net loss of ₹10.68 Cr for the period. Consolidated figures showed revenue at ₹423.55 Cr, reporting a net loss attributable to owners of ₹9.96 Cr. Key board changes include the proposed re-appointment of Mr. Joseph Conrad D’Souza as an Independent Director for a second five-year term, subject to shareholder approval. Mr. Hari Rajmohan was appointed as an Alternate Director. Additionally, Mr. Santosh Parab, the CFO, has taken interim charge of the Human Resources & Administration Department following a resignation.